Ja-young Jeon
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Long-Term Use of Oral Corticosteroids and Safety Outcomes for Patients With Atopic Dermatitis.
Journal: JAMA network open
Published: July 19, 2024
Comparative effectiveness of tofacitinib and tumour necrosis factor inhibitors in patients with rheumatoid arthritis in real-world practice: a prospective observational study.
Journal: Rheumatology (Oxford, England)
Published: September 21, 2023
Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective study.
Journal: Scientific reports
Published: November 01, 2022
Comparisons of treatment satisfaction and health-related quality of life in patients with rheumatoid arthritis treated with tofacitinib and adalimumab.
Journal: Arthritis research & therapy
Published: October 14, 2022
Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway.
Journal: Biomedicines
Published: March 29, 2022
Real-world treatment patterns for atopic dermatitis in South Korea.
Journal: Scientific reports
Published: March 28, 2022
Hospital Utilization and Medication Prescriptions among Patients with Atopic Dermatitis in South Korea: A Real-World Data Analysis.
Journal: Annals of dermatology
Published: February 06, 2022
Safety and effectiveness of tofacitinib in Korean adult patients with rheumatoid arthritis: A post-marketing surveillance study.
Journal: Modern rheumatology
Published: December 24, 2021
Treatment pattern, satisfaction, and productivity loss of patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors in Korea: A multicenter cross-sectional observational study.
Journal: International journal of rheumatic diseases
Published: August 04, 2021
The risk factors and incidence of major infectious diseases in patients with ankylosing spondylitis receiving tumor necrosis factor inhibitors.
Journal: Modern rheumatology
Published: January 26, 2021
Real-World Incidence of Suboptimal Response to Anti-Tumor Necrosis Factor Therapy for Ulcerative Colitis: A Nationwide Population-Based Study.
Journal: Gut and liver
Published: November 23, 2020
Dose Reduction of Tumor Necrosis Factor Inhibitor and its Effect on Medical Costs for Patients with Ankylosing Spondylitis.
Journal: Rheumatology and therapy
Published: November 18, 2020
Last Updated: 09/26/2026